![Jean-Pierre Sommadossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 31 M $ in data 30/06/2026
Il dott. Jean-Pierre Sommadossi è presidente di Kezar Life Sciences, Inc., presidente, presidente e amministratore delegato di Atea Pharmaceuticals, Inc., membro del consiglio di ricerca della Harvard Medical School e amministratore indipendente della ABG Acquisition Corp. I. Fa parte del consiglio di amministrazione di Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. e ABG Acquisition Corp. I. Il Dr. Sommadossi è stato precedentemente impiegato come presidente, presidente e amministratore delegato di Idenix Pharmaceuticals LLC, co-fondatore di Pharmasset, Inc., professore dell'Università dell'Alabama a Birmingham, Fogarty Fellow del Medical College of Virginia, Fogarty Fellow del National Cancer Institute e consigliere di Puretech Health LLC. È stato anche membro del consiglio di amministrazione di Alzheon, Inc. e Kinex Pharmaceuticals, Inc. Ha ricevuto il suo dottorato all'Università di Marsiglia.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/04/2026 | 6.633.855 ( 8,29% ) | 31 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Amministratore Delegato | 01/12/2012 |
| ABG ACQUISITION CORP. I | Direttore/Membro del Consiglio | 01/02/2021 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Direttore/Membro del Consiglio | 01/01/2004 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Presidente | 01/01/2015 |
| Società | Posizione | Fine |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Presidente | 11/05/2022 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Presidente | 01/01/2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2021 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Direttore/Membro del Consiglio | 01/11/2020 |
| ATHENEXPAR | Direttore/Membro del Consiglio | 01/07/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
